Evidence map›Paper›PMID 23369397›Full record

ArticleClinical and translational medicine2012

The international effort: building the bridge for Translational Medicine: Report of the 1st International Conference of Translational Medicine (ICTM).

Xiaoming Chen, Roland Andersson, William Cs Cho, David Christiani, Richard Coico, Jeffery Drazen, Markus Ege, Thomas Fehniger, Hongwei Gao, Kunlin Jin and 14 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. A proteomic approach to obesity and type 2 diabetes.Journal of cellular and molecular medicine · 2015
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 16 institutions in 10 countries.

Xiaoming ChenInfectious Disease and Immunogenetics Section (IDIS), Department of Transfusion Medicine, Clinical Center and Center for Human Immunology (CHI), NIH, Bethesda MD, USA. ewang@mail.nih.gov.
Roland Andersson
William Cs Cho
David Christiani
Richard Coico
Jeffery Drazen
Markus Ege
Thomas Fehniger
Hongwei Gao
Kunlin Jin
Michael N Liebman
Elena Lopez
Giuseppe Marraro
Gyorgy Marko-Varga
Francesco M Marincola
Laurentiu M Popescu
Claudio Spada
Aamir Shahzad
Ena Wang
Wei Wang
Xiangdong Wang
Yong-Xiao Wang
Jinglin Xia
Jia Qu
Fudan University · CNHarvard University · USLund University · SEWenzhou Medical University · CNAlbany Medical Center Hospital · USCenter for Pain and the Brain · USEdith Cowan University · AUFatebenefratelli Hospital · ITHospital Universitario 12 De Octubre · ESNational Institute of Advanced Studies · INQueen Elizabeth Hospital · CNStrategic Analysis (United States) · USSUNY Downstate Health Sciences University · USTallinn University of Technology · EEUniversity of North Texas Health Science Center · USUniversity of Vienna · AT

Funding

Signaling Mechanisms for Hypoxic Pulmonary VasoconstrictionR01HL108232 · NHLBI · ALBANY MEDICAL COLLEGE · PI WANG, YONG-XIAO · 2012 to 2015
$1.5M
NHLBI NIH HHS R01 HL108232
6 · The paper itself

Abstract

unlabelled

backgroundSupported by the International Society for Translational Medicine (ISTM), Wenzhou Medical College and the First Affiliated Hospital of Wenzhou Medical College, the International Conference on Translational Medicine (ICTM) was held on October 22-23, 2011 in Wenzhou, China. Nearly 800 registrants attended the meeting, primarily representing institutes and hospitals in Europe, The United States of America, And Asia, and China. The meeting was chaired and organized by Dr. Xiangdong Wang, Xiaoming Chen, Richard Coico, Jeffrey M. Drazen, Richard Horton, Francesco M. Marincola, Laurentiu M. Popescu, Jia Qu and Aamir Shahzad.

findingsThe meeting focused on the communication of the need to foster translational medicine (TM) by building and broadening bridges between basic research and clinical studies at the international level. The meeting included distinguished TM experts from academia, the pharmaceutical and diagnostics industries, government agencies, regulators, and clinicians and provided the opportunity to identify shared interests and efforts for collaborative approaches utilizing cutting edge technologies, innovative approaches and novel therapeutic interventions. The meeting defined the concept of TM in its two-way operational scheme and emphasized the need for bed to bench efforts based directly on clinical observation.

conclusionsIt was the meeting participants' realization that the shared main goals of TM include breaking the separation between clinic practice and basic research, establishing positive feedback by understanding the basis of expected and unexpected clinical outcomes and accelerating basic research relevant to human suffering. The primary objectives of the meeting were two-fold: to accelerate the two-way translation by informing the participants representing the different disciplines about the state of art activities around TM approaches; and to identify areas that need to be supported by redirecting limited resources as well as identifying new sources of funding. This report summarizes key concepts presented during the meeting representing the state-of-art translational research and salient aspects of the ensuing discussions.

Identifiers

PMID23369397
PMCPMC3561055
OpenAlexW2098534547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.